Galapagos NV (GLPGa)

BATS Europe
Currency in EUR
23.88
+1.68(+7.57%)
Closed
GLPGa Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
23.8823.88
52 wk Range
22.2033.17
Key Statistics
Edit
Bid/Ask
26.26 / 25.96
Prev. Close
22.2
Open
23.88
Day's Range
23.88-23.88
52 wk Range
22.2-33.17
Volume
483
Average Volume (3m)
266
1-Year Change
-32%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GLPGa Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Galapagos NV Company Profile

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Compare GLPGa to Peers and Sector

Metrics to compare
GLPGa
Peers
Sector
Relationship
P/E Ratio
−1,229.5x−2.5x−0.7x
PEG Ratio
18.78−0.110.00
Price/Book
0.5x1.4x2.6x
Price / LTM Sales
5.7x7.6x3.1x
Upside (Analyst Target)
-169.9%46.7%
Fair Value Upside
Unlock3.8%8.1%Unlock

Earnings

Latest Release
Feb 12, 2025
EPS / Forecast
0.37 / -0.3572
Revenue / Forecast
83.50M / 71.08M
EPS Revisions
Last 90 days

People Also Watch

1,840.00
ADYEN
+1.94%
102.50
TEPRF
+2.50%
12.80
TKWY
+0.55%
27.22
MT
-1.73%
43.03
PRX
+4.70%

FAQ

What Is the Galapagos NV (GLPGa) Stock Price Today?

The Galapagos NV stock price today is 23.88

What Stock Exchange Does Galapagos NV Trade On?

Galapagos NV is listed and trades on the BATS Europe stock exchange.

What Is the Stock Symbol for Galapagos NV?

The stock symbol for Galapagos NV is "GLPGa."

What Is the Galapagos NV Market Cap?

As of today, Galapagos NV market cap is 1.58B.

What is Galapagos NV Earnings Per Share?

The Galapagos NV EPS is 1.12.

What Is the Next Galapagos NV Earnings Date?

Galapagos NV will release its next earnings report on Apr 22, 2025.

From a Technical Analysis Perspective, Is GLPGa a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.